This protein plays a crucial role in the β-oxidation pathway, which is essential for cellular energy production 32 Our study identify DECR2 as a potential therapeutic target for Alzheimer's disease (AD). Here, DECR2 is linked to early-onset autosomal dominant Alzheimer disease.